Trevi Therapeutics Overview
Trevi Therapeutics Target Price
Analysts' 12-month price predictions for TRVI.
Get informed when a big investor buys or sells
+ FollowShare Price
$17.71
Average Target Price
$25.00
41.2% upside
41.2% upside2 analysts in the last 4 months
High: $30 | Low: $20
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-08 | Stifel NicolausAnnabel Samimy | $30 | 69.4% upside |  |
| 2026-05-06 | Morgan Stanley | $20 | 12.9% upside | |
| 2025-12-19 | Stifel Nicolaus | $18 | 1.6% upside | |
| 2025-11-19 | Leerink PartnersRoanna Ruiz | $16 |  9.7% downside | |
| 2025-11-14 | Morgan StanleyJudah Frommer | $19 | 7.3% upside | |
| 2025-11-14 | OppenheimerLeland Gershall | $24 | 35.5% upside | |
| 2024-10-22 | H.C. WainwrightOren Livnat | $6 | 66.1% downside | |
| 2024-10-04 | B.Riley FinancialMayank Mamtani | $6 | 66.1% downside | |
| 2022-07-09 | OppenheimerLeland Gershall | $12 | 32.2% downside | |